Your browser doesn't support javascript.
loading
Immunogenicity Risk Assessment of Spontaneously Occurring Therapeutic Monoclonal Antibody Aggregates.
Swanson, Michael D; Rios, Shantel; Mittal, Sarita; Soder, George; Jawa, Vibha.
Affiliation
  • Swanson MD; Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck Research Laboratories, Merck & Co., Inc., Kenilworth, NJ, United States.
  • Rios S; Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck Research Laboratories, Merck & Co., Inc., Kenilworth, NJ, United States.
  • Mittal S; Analytical R&D, Merck Research Laboratories, Merck & Co., Inc., Kenilworth, NJ, United States.
  • Soder G; Analytical R&D, Merck Research Laboratories, Merck & Co., Inc., Kenilworth, NJ, United States.
  • Jawa V; Nonclinical Disposition and Bioanalysis, Bristol Myers Squibb, Princeton, NJ, United States.
Front Immunol ; 13: 915412, 2022.
Article in En | MEDLINE | ID: mdl-35967308
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Main subject: Leukocytes, Mononuclear / Antibodies, Monoclonal Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Front Immunol Year: 2022 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Main subject: Leukocytes, Mononuclear / Antibodies, Monoclonal Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Front Immunol Year: 2022 Type: Article